# Translational Neural Devices (R61/R33 - Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is ex...

Canonical page: https://grantsonar.com/grants/opportunity/translational-neural-devices-r61-r33-clinical-trial-optional-1e9d49b4-4765-4df7-adc7-adbdcfa2cc00
Source: grants_gov
Source ID: 356903
Last confirmed Oct 13, 2026 · Grants.gov
Deadline: January 28, 2027
Award size: not disclosed

## Answer-first Q&A

### Who is eligible for Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) eligibility includes eligible applicants named in the notice. Geographic eligibility is national or notice-specific geography; applicants should confirm the source notice before applying.

### What is the deadline for Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) has a listed deadline of January 28, 2027. Grant deadlines can change, so verify the current date with National Institutes of Health before submitting.

### How much funding is available for Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.

### Who funds Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) is funded by National Institutes of Health. GrantSonar tracks the notice with source ID 356903 from grants_gov.